Literature DB >> 18450333

Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models.

Ruxandra Draghia-Akli1, Amir S Khan, Patricia A Brown, Melissa A Pope, Ling Wu, Lauren Hirao, David B Weiner.   

Abstract

Enhancing the expression of DNA vaccines requires that specific conditions of delivery are optimized. We describe experiments using adaptive constant-current electroporation (EP) in mice and pigs examining parameters such as target muscle, delay between plasmid delivery and onset of EP pulses and DNA vaccine formulation; our studies show that concentrated formulations result in better expression and immunogenicity. Furthermore, various conditions of EP that limit the amount of muscle damage were measured. The results of these studies will help to advance the success of DNA vaccines in animals into success in human clinical trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450333     DOI: 10.1016/j.vaccine.2008.03.071

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses.

Authors:  Richard J Connolly; Taryn Chapman; Andrew M Hoff; Michele A Kutzler; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

Review 2.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

3.  Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit.

Authors:  Antonio Valentin; Agneta von Gegerfelt; Margherita Rosati; Georgios Miteloudis; Candido Alicea; Cristina Bergamaschi; Rashmi Jalah; Vainav Patel; Amir S Khan; Ruxandra Draghia-Akli; George N Pavlakis; Barbara K Felber
Journal:  Vaccine       Date:  2010-02-23       Impact factor: 3.641

Review 4.  Electroporation advances in large animals.

Authors:  Scott D Reed; Shulin Li
Journal:  Curr Gene Ther       Date:  2009-08       Impact factor: 4.391

5.  Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.

Authors:  Feng Lin; Xuefei Shen; Gleb Kichaev; Janess M Mendoza; Maria Yang; Philip Armendi; Jian Yan; Gary P Kobinger; Alexander Bello; Amir S Khan; Kate E Broderick; Niranjan Y Sardesai
Journal:  Hum Gene Ther Methods       Date:  2012-07-13       Impact factor: 2.396

6.  Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array.

Authors:  B Ferraro; L C Heller; Y L Cruz; S Guo; A Donate; R Heller
Journal:  Gene Ther       Date:  2010-12-23       Impact factor: 5.250

7.  Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation.

Authors:  Y Sun; S Peng; A Yang; E Farmer; T-C Wu; C-F Hung
Journal:  Gene Ther       Date:  2017-05-11       Impact factor: 5.250

8.  Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation.

Authors:  Kate E Broderick; Amy Chan; Feng Lin; Xuefei Shen; Gleb Kichaev; Amir S Khan; Justin Aubin; Tracy S Zimmermann; Niranjan Y Sardesai
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-14       Impact factor: 10.183

9.  Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens.

Authors:  Dominick J Laddy; Jian Yan; Michele Kutzler; Darwyn Kobasa; Gary P Kobinger; Amir S Khan; Jack Greenhouse; Niranjan Y Sardesai; Ruxandra Draghia-Akli; David B Weiner
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

10.  Targeted Collection of Plasmid DNA in Large and Growing Animal Muscles 6 Weeks after DNA Vaccination with and without Electroporation.

Authors:  Daniel Dory; Vincent Le Moigne; Roland Cariolet; Véronique Béven; André Keranflec'h; André Jestin
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.